BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6666913)

  • 1. [Arterial hypertension with secondary hyperaldosteronism, reversible by nifedipine, in systemic scleroderma].
    Gouet D; Rouffineau J; Marechaud R; Thomas P; Pourrat O; Alcalay M; Bontoux D
    Ann Med Interne (Paris); 1983; 134(8):736-8. PubMed ID: 6666913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible acute renal faiure in diffuse scleroderma.
    Ponticelli C; Ambroso G; Graziani G; Rossi E
    Clin Nephrol; 1980 Jun; 13(6):293-5. PubMed ID: 7408249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microangiopathy and arterial hypertension in scleroderma and periarteritis nodosa].
    Cacoub P; Guillevin L
    J Mal Vasc; 1986; 11(3):282-7. PubMed ID: 2877044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful percutaneous angioplasty of renal artery in a patient with severe arterial hypertension and symptoms of hyperaldosteronism: a case report].
    Skrzypiec-Spring M; Spring A; Poczatek K; Nowicki P; Derkacz A; Ciesielska A; Negrusz-Kawecka M; Mazurek W
    Kardiol Pol; 2006 Jul; 64(7):724-6; discussion 726-7. PubMed ID: 16886129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a single dose of nifedipine on the CO transfer capacity in patients with scleroderma].
    Orvoen-Frija E; Dore MF; Fiessinger JN; Rochemaure J
    Rev Mal Respir; 1989; 6(6):525-9. PubMed ID: 2602627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism].
    Frisina N; Buemi M; Ciraolo O; Naso G; Lasco A; Costa G
    Boll Soc Ital Biol Sper; 1980 Nov; 56(22):2284-8. PubMed ID: 7013771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperaldosteronism in hypertension].
    Girerd X
    Rev Med Suisse; 2008 Sep; 4(170):1924-6. PubMed ID: 18847121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypernephroma and hypertension. Two case reports.
    Dahl T; Eide I; Fryjordet A
    Acta Med Scand; 1981; 209(1-2):121-4. PubMed ID: 7010927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value and limitations of calcium channel blockade in the treatment of pulmonary hypertension associated with CREST--case reports.
    Pressly TA; Winkler A; Alpert MA; Jackson RW; Mukerji V; Benge JM; Sharp GC
    Angiology; 1988 Apr; 39(4):385-9. PubMed ID: 3364805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a calcium antagonist, nifedipine, on arterial pressure and plasma renin activity in subjects with essential arterial hypertension].
    Santucci A; Aguglia F; De Mattia G; Cicconetti P; Kukaki S
    Clin Ter; 1981 Apr; 97(2):175-82. PubMed ID: 7016416
    [No Abstract]   [Full Text] [Related]  

  • 14. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nifedipine in the therapy of secondary hypertension].
    Bartorelli A; Fiorentini C; Fabbiocchi F; Loaldi A; Guazzi M
    Boll Soc Ital Cardiol; 1981; 26(10):935-7. PubMed ID: 7349176
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of indomethacin and ibuprofen on blood pressure of patients treated with nifedipine or captopril].
    Halawa B
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):313-5. PubMed ID: 8415243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
    Mychka VB; Chazova IE; Dmitriev VV; Masenko VP
    Ter Arkh; 2000; 72(9):10-3. PubMed ID: 11076407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma crisis: progressive renal failure despite blood-pressure control.
    DiPette DJ; Daisley SJ; Fragola JA
    Clin Pharm; 1983; 2(2):179-81. PubMed ID: 6349906
    [No Abstract]   [Full Text] [Related]  

  • 19. [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
    Denolle T; Hanon O; Mounier-Vehier C; Marquand A; Fauvel JP; Laurent P; Tison E; Equine O; Ducloux D; Girerd X
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1037-9. PubMed ID: 10989753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.